Colleagues:
I'm genuinely puzzled as to the reason why we should have seen five
applications published during the past two weeks (one EP and four PCTs)
seeking to claim new methods of using sildenafil (three of them intranasal,
of all things). Those reading Current Patents Gazette will have seen our
editorial comments. It may just be coincidence that all five companies (one
of them Pfizer) have independently conceived a new route of administration
and decided to to file an appropriate patent application - or it may be that
something happened in May or June of 1998 to trigger this simultaneous
creative outpouring. Does anyone out there know the answer?
I'd appreciate your comments.....
Peter Steele
Managing Director, Current Patents Ltd
Middlesex House, 34-42 Cleveland Street
London W1P 6LB, UK
Tel: +44 (0)171 323 0323
Fax: +44 (0)171 580 5646
E-mail: peter.steele@cursci.co.uk
This archive was generated by hypermail 2b29 : Fri Aug 10 2001 - 15:58:02 EDT